J&J’s One-Shot Vaccine Shows 66% Efficacy, But Company Says There’s More To It

Prevention Of Severe Disease Consistent Across Geographies

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.